Personalized Medicine Market Share, Size & Demand by 2034

Coverage: by Product (PM Diagnostics, PM Therapeutics, Personalized Medical Care, Personalized Nutrition and Wellness), and Geography (North America, Europe, Asia Pacific, and South and Central America)

Historic Data: 2021-2024 | Base Year: 2025 | Forecast Period: 2026-2034
  • Status : Data Released
  • Report Code : TIPRE00008499
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format
  • Last update date : April 28, 2026
Personalized Medicine Market Share, Size & Demand by 2034
Report Date: April 28, 2026   |   Report Code: TIPRE00008499 Email: sales@theinsightpartners.com

2025 Market Size

US$ 591.32 Bn

Base year value

2034 Forecast

US$ 1,220.03 Bn

Projected by 2034

CAGR 2026-2034

8.38 %

Growth rate

Addressable Market

US$ 8,131.01 Bn

(2026-2034)

The Personalized Medicine Market size is expected to reach US$ 1,220.03 Billion by 2034 from US$ 591.32 Billion in 2025. The market is estimated to record a CAGR of 8.38% from 2026 to 2034.

The Personalized Medicine Market report covers analysis by Product (PM Diagnostics, PM Therapeutics, Personalized Medical Care, Personalized Nutrition and Wellness). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.

Purpose of the Report

The report Personalized Medicine Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  1. Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  2. Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  3. Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Personalized Medicine Market Segmentation

Product

  1. PM Diagnostics
  2. PM Therapeutics
  3. Personalized Medical Care
  4. Personalized Nutrition and Wellness

Market Research Highlights

  • Global market for Personalized Medicine was valued at US$ 591.32 Billion in 2025
  • Annual market size is expected to reach US$ 1,220.03 Billion by 2034
  • Total addressable market (TAM) during 2026-2034 is projected to reach approximately US$ 8,131.01 Billion
  • Market is anticipated to register a CAGR of 8.38% during the forecast period
  • The United States represents a key market, supported by Advances in Genomic Research, Sequencing Technologies and Market Growth, Rising Chronic Diseases, as well as evolving industry dynamics
  • Market analysis covers North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa, with growth evaluated across the forecast period
  • Market opportunities such as Aging Population and Demand for Tailored Solutions, Targeting the Elderly Demographic, Regulatory Support and Market Opportunities are expected to influence market dynamics and addressable market
  • Report profiles industry participants, including Abbott Laboratories, Amgen, Inc., AstraZeneca, Bayer AG, Eli Lilly and Company, GlaxoSmithKline plc., Merck & Co., Inc, Mylan N.V., Novartis AG, Pfizer, Inc., while analyzing competitive strategies and innovation developments
  • Source: The Insight Partners' analysis based on proprietary research, government publications, company annual reports, investor presentations, industry databases, and expert interviews.

● REPORT CUSTOMIZATION

Tailor This Report To Align With Your Specific Business Requirements

This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.

Customize This Report →

WHAT YOU CAN ADJUST

  • Segmentations
  • Geography
  • Competitive Analysis
  • Language Preferences

Personalized Medicine Market: Strategic Insights

personalized-medicine-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Personalized Medicine Market Growth Drivers

  1. Advances in Genomic Research: Rapid growth in the genomic field, leading to a surge in personal medicine tailored to genetic profiles.
  2. Sequencing Technologies and Market Growth: Advancements in sequencing technologies driving market growth and creating a dynamic competitive landscape.
  3. Rising Chronic Diseases: Increased incidence of chronic diseases like cancer, diabetes, and cardiovascular disorders fueling demand for personalized treatments.
  4. Value-Based Care and Individualized Treatment: Healthcare providers focusing on value-based care with individualized treatment for improved patient outcomes.

Personalized Medicine Market Future Trends

  1. Biotech Firms and SWOT Analysis: The growing role of biotech firms in personalized medicine highlighted through SWOT analysis.
  2. Collaborations in AI, Big Data, and Genomics: Pharmaceutical and tech-based firm collaborations in AI, big data, and genomics enhancing treatment options and boosting personalized medicine.
  3. Optimistic Market Predictions: Market forecasts show steady growth in personalized medicine, driven by ongoing innovations and collaborations.

Personalized Medicine Market Opportunities

  1. Aging Population and Demand for Tailored Solutions: Growing elderly population in developed countries driving demand for personalized medicine to manage chronic diseases.
  2. Targeting the Elderly Demographic: Companies can capture the elderly demographic by providing tailored, data-driven treatments for specific health concerns.
  3. Regulatory Support and Market Opportunities: Enhanced government regulatory support for personalized medicine creating new market opportunities for companies.

Personalized Medicine Market Report Scope

Report Attribute Details
Market size in 2025 US$ 591.32 Billion
Market Size by 2034 US$ 1,220.03 Billion
Global CAGR (2026 - 2034) 8.38%
Historical Data 2021-2024
Forecast period 2026-2034
Segments Covered By Product
  • PM Diagnostics
  • PM Therapeutics
  • Personalized Medical Care
  • Personalized Nutrition and Wellness
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Abbott Laboratories
  • Amgen, Inc.
  • AstraZeneca
  • Bayer AG
  • Eli Lilly and Company
  • GlaxoSmithKline plc.
  • Merck & Co., Inc
  • Mylan N.V.
  • Novartis AG
  • Pfizer, Inc.

Personalized Medicine Market Players Density: Understanding Its Impact on Business Dynamics

The Personalized Medicine Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

personalized-medicine-market-cagr

Key Selling Points

  1. Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Personalized Medicine Market, providing a holistic landscape.
  2. Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  3. Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  4. Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Personalized Medicine Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


Frequently Asked Questions

Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

Key companies of this market are: Abbott Laboratories, Amgen, Inc., AstraZeneca, Bayer AG, Eli Lilly and Company, GlaxoSmithKline plc., Merck & Co., Inc, Mylan N.V., Novartis AG,

Key future trends in this market are - Advancements in Genomic Technologies, Increasing Demand for Targeted Therapies, Collaborations Between Pharma and Tech Companies

The Personalized Medicine Market is estimated to witness a CAGR of 8.38% from 2026 to 2034

The major factors driving the Market are: Genomics and diagnostics advancements, Rising chronic disease prevalence, Shift to value-based care
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA